EN
HI
Novartis India Share price
NOVARTIND
1418.9
63.30 (-4.27%)NSE
BSE
Last updated on 21 Aug, 2026 | 15:59 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Novartis India share price chart
Novartis India Share Key Metrics
Volume
29213.00
Market Cap
3503.38 CR
LTQ@LTP
10@1418.90
ATP
1436.01
Var Margin
20.06 %
Circuit Range
1185.8-1778.6
Delivery %
64.26 %
Value
4.20 CR
ASM/GSM
No
Market Lot
1
Summary
NOVARTIND stock price is ₹1418.9 as of 21 Aug, 2026. The stock intraday movement has stayed between ₹1402.00 and ₹1510.00, while Novartis India share price 52 week high low is ₹950.00 & ₹1780.00.
In terms of trading activity, NOVARTIND share price has recorded a volume of 29,213 shares. The Novartis India has a market cap of ₹24690797. The stock’s Average Traded Price (ATP) stands at ₹1436.01, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹1418.90.
The Novartis India upper circuit limit is ₹1778.60 & The Novartis India lower circuit limit is ₹1185.80, with a Value of ₹4.20 CR. The Delivery Percentage for the day is 64.26%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Novartis India Resistance and Support
Pivot 1511.03
Resistance
First Resistance
1546.06
Second Resistance
1609.93
Third Resistance
1644.96
Support
First Support
1447.16
Second Support
1412.13
Third Support
1348.26
Novartis India Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
70.68%
Mutual Fund
0%
Insurance
0.51%
Foreign Institutional Investors
0.19%
Domestic Institutional Investors
0.01%
Retail
28.61%
Others
0%
Total Promoters
MAR '24
70.68%
JUN '24
70.68%
SEP '24
70.68%
DEC '24
70.68%
Novartis India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-07-23 | 2025-07-23 | View More |
Novartis India News
Novartis India Ltd - 500672 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On August 17, 2026
Novartis India's Board of Directors approved a proposal to change the company's name and make consequential alterations to its Memorandum and Articles of Association. The board also approved a new Memorandum of Association to align with the Companies Act, 2013. Both resolutions require shareholder approval at the upcoming Annual General Meeting.
Aug 17 2026 19:51:24
Novartis India Ltd - 500672 - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 07, 2026
Novartis India Limited's board approved the termination of its distribution and promotion agreement with Dr. Reddy's Laboratories Limited. This enables Novartis to re-acquire exclusivity and direct market access for specific products from September 30, 2026.
Aug 07 2026 20:52:54
Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
ChrysCapital has acquired a controlling 70.68% stake in Novartis India Limited. Dr. Vikas Gupta has been appointed MD & CEO, along with new Independent Directors, to drive strategy for a branded-generics platform.
Jul 29 2026 21:38:33
Novartis India Ltd - 500672 - Disclosure In Terms Of Regulation 29(2) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) ("SAST"), 2015.
Promoter Novartis AG sold 1.74 crore equity shares, representing 70.68% of Novartis India. The transaction was an off-market sale, resulting in Novartis AG ceasing to be a promoter and being reclassified as a public shareholder.
Jul 29 2026 19:22:00
Novartis India Ltd - 500672 - Disclosure In Terms Of Regulation 7(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015.
Novartis AG, the erstwhile promoter of Novartis India, sold 1,74,50,680 equity shares, representing 70.68% of the company's share capital, through an off-market transaction on July 29, 2026. The sale was valued at Rs. 137.69 crore, marking a major change in ownership.
Jul 29 2026 18:59:21
Novartis India Ltd - 500672 - Intimation Under Regulation 31A (10) And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, ("SEBI Listing Regulations").
Novartis India's promoter, Novartis AG, has been reclassified from 'Promoter' to 'Public' category. This follows the divestment of a 70.68% equity stake to WaveRise Investments Limited and ChrysCapital Fund X, transferring company control on July 29, 2026.
Jul 29 2026 18:40:42
Novartis India Ltd - 500672 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners collectively acquired a 70.68% stake in Novartis India Limited. These entities are now classified as the promoters, having gained control through an off-market transfer.
Jul 29 2026 17:15:31
Novartis India Ltd - 500672 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited Held On Thursday, July 23, 2026.
Novartis India's board approved Q1 FY27 financial results on July 23, 2026. Revenue rose 18.57% YoY to ₹103.81 crores, and net profit increased 16.62% YoY to ₹32.21 crores, along with the Limited Review Report.
Jul 23 2026 12:54:23
Read More
Novartis India Management
| Name | Position |
|---|---|
| Chandni Maru | Company Secretary & Compliance Officer |
| Christopher Snook | Chairperson |
Novartis India Similar Stocks
BLS E-Services Ltd.
320.90
-0.20 (0.06%)
Vimta Labs Ltd.
629.65
-10.75 (1.68%)
EFC (I) Ltd.
191.61
0.95 (0.50%)
Fischer Medical Ventures Ltd.
38.14
-0.81 (2.08%)
Elitecon International Ltd.
15.70
-1.09 (6.49%)
Flair Writing Industries Ltd.
248.80
-4.20 (1.66%)
Medi Assist Healthcare Services Ltd.
360.75
4.85 (1.36%)
SIRCA Paints India Ltd.
451.20
1.45 (0.32%)
Knack Packaging Ltd.
203.55
-5.62 (2.69%)
Confidence Petroleum India Ltd.
74.80
2.64 (3.66%)
Novartis India FAQs
The Buying Price of Novartis India share is 1418.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Novartis India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novartis India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Novartis India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Novartis India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Novartis India’s valuation compare Sector P/E, P/B which are 58.07 & 2.15 with sector averages, along with growth rates and financial metrics.
The Market Cap of Novartis India is 3503.38 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Novartis India share price is 1780.00 & 950.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Novartis India belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in NOVARTIND
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC